Join Medical Chronicle for an illuminating webinar exploring the treatment landscape of actinic keratosis within the South African context.
If you missed this free, one-hour, CPD-accredited webinar on Understanding the treatment of actinic keratosis: The South African context, please click here to watch the replay.
This webinar is sponsored by iNova Pharmaceuticals.
Actinic keratosis is the most common actinic lesion among fair-skinned populations. It is exceedingly common in South Africa due to our high rates of sun exposure. Current president of the Dermatological Society of South Africa, Dr Noufal Raboobee, will place the condition in its local context and explain the optimal treatment approaches currently available.
ABOUT DR RABOOBEE
Dr Raboobee obtained his MBChB at the University of Natal, South Africa in 1983 and went on to complete his FFDerm(SA) though the College of Medicine of South Africa in 1989. He has been in private practice at Westville Hospital for the past 33 years. Dr Raboobee is currently the President of the Dermatological Society of South Africa and the Vitiligo Society of South Africa. He serves on the Medical Advisory board of the Global Vitiligo Foundation and is a member of the International Vitiligo Task Force, contributing to its publications.
He has been instrumental in introducing several surgical techniques in vitiligo to South Africa. He has written a book chapter on phototherapy in Moschella and Hurley’s Dermatology in 2020. He has chaired the Psoriasis Advisory Board, during which time the guidelines for the treatment of Psoriasis were produced and published in the SAMJ by the board members.
He currently chairs the committee which is updating the psoriasis guidelines and is a coauthor of the recent update to the international guidelines of vitiligo. He remains on the advisory boards of all the biologics suppliers in South Africa and has has contributed as co-author to the Childhood Atopic Eczema Consensus Document, published in the SAMJ. He has participated in the Advisory Board for Acne during the revision of the guidelines for the use of isotretinoin and has published a photographic series of patients on isotretinoin.
He has served as a senior lecturer at the Nelson Mandela School of Medicine, a visiting consultant at King Edward VIII, Inkosi Albert Luthuli and Addington Hospitals in Durban and as an examiner for the College of Medicine of South Africa. Dr Raboobee has participated as an invited faculty member in several congresses held in various countries, the last of which was the World Congress of Dermatology in Singapore in 2023. His special interests include Surgical treatment of Vitiligo, Excimer Laser, biologic therapy of psoriasis and atopic dermatitis, Immunotherapy of viral warts and management of skin cancers.
